# Milestone 14 Transition Review

**Document Version:** 1.0

**Status:** Approved Outcome - Published

**Milestone:** Milestone 14

**Review Date:** 2026-07-24

---

## Purpose

This artifact publishes the approved Milestone 14 Transition Review outcome.

It records the completed review. It does not repeat or redesign the review, modify the Engineering Lifecycle, create a Transition Review template, expand governance, authorize live work, or implement EO-15.1.

---

## Milestone Accomplishment Review

Milestone 14 operationalized the AI Engineering Organization through the governed Container Operational Health vertical slice while preserving the distinction between repository implementation, architecture approval, activation, deployment, observation, and live operation.

| Portfolio Pillar | Approved Accomplishment | Repository Evidence |
|------------------|-------------------------|---------------------|
| Engineering Organization | AI Collaboration Governance was published; governed AI session initialization, continuity, completion, readiness validation, and evidence visibility became repository capabilities. EO-14.1A Execution Capability and EO-14.4A Governed Automation repository implementations were published without activating either role or automation. | EO-14.8 artifacts and reports; Execution Capability; Governed Automation Framework; Engineering Organization roadmap and backlog. |
| Shared Platform | Platform Operations became a bounded architecture domain. Registry Container Identity schema `1.1`, evidence-gated migration, exact approval binding, rollback, and write-free second-run behavior were published. The fixture-only Container Operational Health slice, provider/proxy foundations, privileged-proxy architecture, transport-free source, and closed socket-capable implementation review were published. | PLAT-14.0A; PLAT-14.1A; ADR-009 through ADR-012; Registry migration evidence; provider, proxy, deployment, source, and review packages. |
| Customer-Facing Application | FFFA customer-value traceability remained governed through the FFFA specifications, personas, reporting contracts, acceptance evidence, and customer data/test isolation and cutover controls. Implementation remained paused rather than converting incomplete customer acceptance into a false completion claim. | Product roadmap and backlog; Engineering Portfolio Kanban; Customer Environment Cutover Checklist; FFFA-owned acceptance evidence referenced by portfolio governance. |

The milestone also strengthened repository validation through focused engineering tests, deterministic evidence reports, and explicit current-state versus planned-state boundaries.

---

## Deferred Work & Waiting on External Events

| Deferred Item | Milestone 14 Closeout State | Next Governing Event |
|---------------|-----------------------------|----------------------|
| FFFA customer acceptance | Not complete; FFFA implementation remains paused and repository-independent. | Complete customer acceptance in the FFFA repository, then obtain the required product and architecture decision before implementation resumes. |
| Repository-only socket-capable privileged-proxy source | Not implemented. The transport review is closed and published, but source authority is separate. | A separately authorized Platform implementation work package. |
| OCI artifact, SBOM/provenance/signature acceptance, privileged deployment, credentials, eligible target, and named-target observation | Not authorized or performed. | Separate artifact, deployment, target, observation, and human production approval gates. |
| Remaining Registry identity decisions | Sixteen subjects remain review-required; Pi-hole remains unresolved and unmigrated. | Subject-specific evidence and exact-plan approval. |
| Charlie Operations Intelligence and Platform Health consumer integration | Not started or remains paused pending governed Platform evidence. | Separately authorized consumer-integration work after required evidence exists. |
| Backup, restore, alerting, controlled updates, and other live Operational Excellence work | Not performed. | Separate architecture and explicit human production authorization. |
| Capability-First Operationalization and secure-provider governance promotion | Not promoted. Evidence is insufficient to establish a repeated successful practice. | Reevaluate only after repeated implementation and approved operational evidence. |

---

## Engineering Learning Review

1. Reusing governed contracts increased delivery leverage. EO-14.4A consumed EO-14.1A assignment, validation, evidence, and completion contracts, and PLAT-14.1A reused both without creating competing authority.
2. Exact evidence binding is essential for governed mutation. The Registry migration work demonstrated that approval must bind an immutable plan, expected post-state, and rollback evidence, and that a second run must be write-free `no_change`.
3. Repository evidence and operational evidence are distinct. Fixture-only health assessment, static safety, transport-free source, and architecture approval do not prove live provider access, deployment enforcement, named-target observation, recurrence, or production readiness.
4. Publication is not activation. Repository implementation, architecture acceptance, artifact acceptance, deployment, observation, consumer integration, recurring execution, and live authorization must remain separate gates.
5. Delivery throughput is constrained when proven controls are repeatedly re-explained rather than reused. Milestone 15 should increase throughput through delivery leverage while preserving the existing authority model.
6. Customer readiness must remain truthful. Technical correctness and portfolio traceability do not substitute for completed FFFA customer acceptance.

---

## Engineering Decision Register Updates

| Decision or Candidate | Milestone 14 Outcome | Carry-Forward State |
|-----------------------|----------------------|---------------------|
| ADR-009 - Evidence Before Operational Health | Published. | Remains authoritative. |
| ADR-010 - Declared, Observed, and Reconciled State | Published. | Remains authoritative. |
| ADR-011 - Canonical Operational Evidence Envelope and Versioned Profiles | Published. | Remains authoritative. |
| ADR-012 - Purpose-Built Constrained Privileged Proxy | Architecture approved; `Implemented: No`. | Socket-capable implementation, artifacts, deployment, observation, and activation remain separately gated. |
| Option C - Governed Vertical Slice | Used for Milestone 14 Container Operational Health. | Historical milestone execution strategy; not promoted into the permanent Engineering Lifecycle. |
| Capability-First Operationalization | Candidate only. | Remains unpromoted pending repeated successful evidence. |
| AB-012 - Secure External and Privileged Provider Integration Standard | Candidate - Remain Backlog. | Reevaluate after approved operational evidence; no promotion is authorized. |

No Engineering Lifecycle change, new lifecycle stage, Transition Review template, or governance expansion was approved by this review.

---

## Portfolio Health Review

| Portfolio Area | Health Finding | Evidence and Constraint |
|----------------|----------------|-------------------------|
| Engineering Organization | Strong governed foundation; delivery leverage is available but not yet fully exploited. | AI Collaboration, Execution Capability, automation orchestration, readiness validation, and deterministic evidence are published; activation remains separate. |
| Shared Platform | Substantial repository implementation and architecture progress; operational completion remains intentionally incomplete. | Platform Operations contracts, Registry migration, fixture-only health, provider/proxy foundations, and transport-free source are published; socket-capable implementation and every live gate remain open. |
| Customer-Facing Application | Customer value is visible, but acceptance is the primary portfolio constraint. | FFFA specifications and acceptance controls are published; customer acceptance is incomplete and implementation remains paused. |
| Governance | Healthy and sufficient for the next milestone. | Existing governance should be reused before any expansion; no new governance is required to initialize Milestone 15. |
| Delivery Throughput | Improvement opportunity identified. | Milestone 14 proved reusable contracts and evidence patterns, but sequencing and repeated gate reconciliation remain delivery friction. |

No numeric maturity score is assigned.

---

## Milestone 15 Portfolio Summary

**Theme:** Increase Engineering Organization Throughput through Delivery Leverage.

Milestone 15 is initialized with four approved directions:

1. Complete FFFA customer acceptance.
2. Deliver additional Platform implementation through separately governed work packages.
3. Operationalize the Transition Review through EO-15.1.
4. Reuse existing governance, contracts, validators, and evidence patterns before expanding governance.

EO-15.1 is authorized for future repository implementation by its governed work package. No EO-15.1 implementation is performed by this Transition Review publication.

Additional Platform implementation, FFFA implementation resumption, live work, role activation, automation activation, artifacts, deployment, observation, consumer integration, and governance promotion remain subject to their existing separate gates.

---

## Related Documents

- [Milestone 14 Closeout Package](Milestone_14_Closeout_Package.md)
- [Milestone 14 Portfolio Plan](Milestone_14_Portfolio_Plan.md)
- [Milestone 15 Portfolio Plan](../Milestone_15/Milestone_15_Portfolio_Plan.md)
- [EO-15.1 Work Package](../Milestone_15/EO_15_1_Engineering_Lifecycle_Transition_Review_Operationalization_Work_Package.md)
- [Engineering Portfolio Kanban](../../portfolio/Engineering_Portfolio_Kanban.md)

---

## Revision History

| Version | Description |
|---------|-------------|
| 1.0 | Published the approved six-section Milestone 14 Transition Review outcome and Milestone 15 portfolio summary. |
